(Q49135439)

18 February 2018

title

Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies. (English)

1 reference

18 February 2018

Parkinson's disease dementia

0 references

1 reference

1 reference

inferred from title

multiple system atrophy

1 reference

dementia with Lewy bodies

inferred from title

1 reference

Spillantini MG

1

1 reference

18 February 2018

publication date

1 December 1999

1 reference

18 February 2018

number of pages

6

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

18 February 2018

volume

5

1 reference

18 February 2018

issue

4

1 reference

18 February 2018

page(s)

157-162

1 reference

18 February 2018

Amyloid, the presenilins and Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Pattern of brain destruction in Parkinson's and Alzheimer's diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Ultrastructural observations in Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Neuropathology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Lewy Bodies of Parkinson's Disease Contain Neurofilament Antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

A large kindred with autosomal dominant Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Identification of two distinct synucleins from human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Cloning and characterization of the cDNA encoding a novel brain-specific 14-kDa protein

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Peripheral nervous system-specific genes identified by subtractive cDNA cloning

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Persyn, a member of the synuclein family, influences neurofilament network integrity

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Organization, expression and polymorphism of the human persyn gene

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Identification, localization and characterization of the human gamma-synuclein gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

The human NACP/alpha-synuclein gene: chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Assignment of human alpha-synuclein (SNCA) and beta-synuclein (SNCB) genes to chromosomes 4q21 and 5q35.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein/NAC precursor that bind Abeta and NAC

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Detection of Lewy bodies in Trisomy 21 (Down's syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Microtubule-associated protein tau, heparan sulphate and alpha-synuclein in several neurodegenerative diseases with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Alpha synuclein in neurodegenerative disorders: murderer or accomplice?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Multiple-system atrophy: a new alpha-synuclein disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

The definition of multiple system atrophy: a review of recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Synthetic filaments assembled from C-terminally truncated alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

Lewy body diseases and multiple system atrophy as alpha-synucleinopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900031-0

7 January 2021

10.1016/S1353-8020(99)00031-0

Identifiers

DOI

1 reference

18 February 2018

PubMed ID

18591134

1 reference

18 February 2018